SUPHA PHARMACHEM LIMITED

About

Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium metal powder, and trimethyl sulfoxonium iodide. It also provides tartaric acid salt, thiophenetosylate, couple amine hydrochloride, pantoprazole sulphide, chloro compound, benzimidazole, pantoprazole n-oxide, 4-chloro benzhydryl piperazine, cetirizine base, levo CBP, 2 PMS, indole II, indole III, and R- amide. The company was formerly known as Remedium Lifecare Limited and changed its name to Supha Pharmachem Limited in December 2025. Supha Pharmachem Limited was incorporated in 1988 and is based in Mumbai, India.

Quarterly Results

Rs. Crores · hover row for definition

Metric	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Sales	8.58	18.37	81.57	38.15	25.08	77.70	1,408.49	1,834.18	468.57	330.46	75.58	176.48	158.45
Expenses	11.57	22.58	82.75	43.63	20.62	77.31	1,443.51	1,779.48	462.23	323.18	78.48	174.95	156.31
Operating Profit	-2.99	-4.21	-1.18	-5.48	4.46	0.39	-35.02	54.70	6.34	7.28	-2.90	1.53	2.14
OPM %	-34.85	-22.92	-1.45	-14.36	17.78	0.50	-2.49	2.98	1.35	2.20	-3.84	0.87	1.35
Other Income	3.25	3.48	0.66	7.43	0.82	1.89	2.89	14.12	4.08	0.00	0.00	0.02	0.06
Depreciation	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Interest	0.19	-0.36	1.59	0.88	2.81	0.00	3.85	0.03	0.00	0.00	-0.10	0.02	0.00
Profit before tax	0.07	-0.37	-2.12	1.06	2.46	2.27	-35.99	68.78	10.41	7.27	-2.81	1.52	2.19
Tax %	0.00	0.00	24.53	27.36	27.64	27.75	49.24	33.38	37.27	27.79	70.11	0.00	0.00
Net Profit	0.07	-0.37	-2.64	0.76	1.78	1.64	-53.72	45.82	6.53	5.25	-4.78	1.52	2.19
EPS in Rs	0.00	0.00	-0.03	0.01	0.02	0.02	-0.60	0.51	0.07	0.06	-0.05	0.02	0.02

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2017	Mar 2016	Mar 2015	Mar 2007
Sales	222.00	4,040.00	510.00	505.00	90.00	3.00	0.00	1.00	4.00	2.00	1.00
Expenses	222.00	4,006.00	502.00	503.00	89.00	2.00	0.00	1.00	4.00	2.00	1.00
Operating Profit	1.00	34.00	8.00	2.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00
OPM %	0.20	0.80	1.60	0.40	0.80	14.00	-44.00	-7.00	-8.00	-8.00	3.40
Other Income	11.00	21.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.00	0.00
Interest	8.00	5.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	4.00	50.00	7.00	2.00	1.00	0.00	0.00	0.00	0.00	1.00	0.00
Tax %	58.00	35.00	27.00	29.00	26.00	24.00	100.00	0.00	0.00	21.00	50.00
Net Profit	2.00	33.00	5.00	1.00	0.00	0.00	0.00	0.00	0.00	1.00	0.00
EPS in Rs	0.02	0.37	0.06	0.01	0.01	0.00	0.00	0.00	0.00	0.01	0.00
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Sep 2025	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2007
Equity Capital	88.00	40.00	10.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00
Reserves	3.00	3.00	33.00	7.00	1.00	0.00	0.00	-1.00	-1.00	-1.00	-1.00	-1.00	0.00
Borrowings	1,088.00	1,141.00	58.00	0.00	0.00	10.00	0.00	0.00	0.00	0.00	0.00	0.00	1.00
Other Liabilities	351.00	355.00	1,847.00	1,144.00	219.00	24.00	1.00	0.00	0.00	0.00	2.00	3.00	1.00
Total Liabilities	1,529.00	1,540.00	1,948.00	1,154.00	224.00	39.00	4.00	4.00	3.00	3.00	5.00	6.00	6.00
Fixed Assets	6.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.00	2.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	9.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	1,515.00	1,540.00	1,948.00	1,154.00	224.00	38.00	4.00	4.00	3.00	3.00	5.00	4.00	4.00
Total Assets	1,529.00	1,540.00	1,948.00	1,154.00	224.00	39.00	4.00	4.00	3.00	3.00	5.00	6.00	6.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	-1,079.00	-74.00	20.00	11.00	-10.00	0.00	0.00	0.00	0.00	-1.00	0.00
Cash from Investing Activity	0.00	0.00	0.00	0.00	0.00	0.00	1.00	0.00	0.00	1.00	0.00
Cash from Financing Activity	1,078.00	54.00	0.00	-11.00	10.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Cash Flow	0.00	-20.00	20.00	1.00	0.00	0.00	1.00	0.00	0.00	0.00	0.00
Free Cash Flow	-1,079.00	-74.00	20.00	11.00	-10.00	0.00	0.00	0.00	0.00	0.00	0.00
CFO/OP %	-199,656.00	-165.00	281.00	641.00	-1,393.00	-50.00	114.00	—	-78.00	453.00	-53.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2007
Debtor Days	969.00	83.00	123.00	46.00	96.00	189.00	319.00	2,117.00	596.00	265.00	341.00	120.00
Inventory Days	455.00	12.00	5.00	—	—	—	—	0.00	0.00	78.00	243.00	1,129.00
Days Payable	542.00	65.00	62.00	—	—	—	—	—	—	129.00	438.00	102.00
Cash Conversion Cycle	882.00	30.00	67.00	46.00	96.00	189.00	319.00	2,117.00	596.00	214.00	146.00	1,147.00
Working Capital Days	69.00	4.00	-8.00	2.00	54.00	323.00	4,745.00	2,159.00	524.00	200.00	107.00	566.00
ROCE %	2.00	100.00	103.00	18.00	7.00	11.00	1.00	1.00	0.00	1.00	—	1.00

Shareholding Pattern

% holding — latest first

Holder	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Promoters	1.13	1.13	1.13	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11
FIIs	1.70	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.04	0.08	0.04	0.00
Public	97.17	98.87	98.87	98.89	98.89	98.89	98.89	98.85	98.86	98.81	98.84	98.88
No. of Shareholders	111,269	114,119	113,543	110,422	73,637	67,404	26,464	15,587	3,859	3,988	1,730	705

Corporate Actions

5 records

Action	Ex Date	Record Date	Ratio	Amount (₹)	Notes
Other	15 Apr 2025	15 Apr 2025	—	—	Right Issue of Equity Shares
Bonus	05 Jul 2024	06 Jul 2024	3:1	—
Split	23 Feb 2024	23 Feb 2024	5:1	—
Split	01 Sep 2023	01 Sep 2023	10:5	—
Bonus	28 Jul 2023	29 Jul 2023	9:5	—